These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 376134)

  • 21. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
    Pasmantier MW; Coleman M; Silver RT; Ballard WP
    Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
    Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
    Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined chemotherapy including platinum derivatives in the combined treatment of patients with stage-III to -IV ovarian cancer].
    Perevodchikova NI; Gorbunova VA; Grigorova TM; Kozachenko VP; Marenich AF
    Vestn Akad Med Nauk SSSR; 1986; (5):8-11. PubMed ID: 3755271
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung.
    Gralla RJ; Cvitkovic E; Golbey RB
    Cancer Treat Rep; 1979; 63(9-10):1585-8. PubMed ID: 498158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
    Pouillart P; Bretaudeau B; Palangie T; Jouve M; Garcia-Giralt E; Asselain B
    Bull Cancer; 1982; 69(5):434-42. PubMed ID: 6891903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative research on different treatment regimens in disseminated cancer of the ovaries].
    Marinov L; Koĭnov K; Tsekova V; Velikova M
    Akush Ginekol (Sofiia); 1987; 26(1):49-52. PubMed ID: 3592111
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide (MAC) in stage III and IV ovarian cancer.
    Ratanatharathorn V; Samson MK; Baker LH; Pollard R; Cummings G; Fraile RJ
    Am J Clin Oncol; 1983 Oct; 6(5):565-70. PubMed ID: 6412538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
    Cohen CJ; Bruckner HW; Goldberg JD; Holland JF
    Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114
    [No Abstract]   [Full Text] [Related]  

  • 32. [Combination of adriamycin and cis-diammine-dichloro-platinum (II) in the treatment of advanced, therapy-resistant, ovarian carcinoma (author's transl)].
    Cavalli F; Stoller U; Tschopp L; Sonntag RW; Brunner KW
    Dtsch Med Wochenschr; 1978 Jun; 103(22):927-31. PubMed ID: 350534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.
    Ehrlich CE; Einhorn L; Stehman FB; Blessing J
    Clin Obstet Gynaecol; 1983 Aug; 10(2):325-35. PubMed ID: 6688562
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).
    McGuire WP; Hoskins WJ; Brady MF; Kucera PR; Partridge EE; Look KY; Clarke-Pearson DL; Davidson M
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):40-7. PubMed ID: 8941409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
    Morgan RJ; Braly P; Cecchi G; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Parker P; Stein A; Cho J; Smith E; Coluzzi P; Najera L; Johnson D; Womack E; Doroshow JH
    Gynecol Oncol; 1999 Dec; 75(3):419-26. PubMed ID: 10600300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide.
    Gershenson DM; Copeland LJ; Kavanagh JJ; Stringer CA; Saul PB; Wharton JT
    Obstet Gynecol; 1987 Nov; 70(5):765-9. PubMed ID: 3658288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy with cis-dichlorodiammineplatinum(II) in disseminated testicular cancer.
    Einhorn LH
    Cancer Treat Rep; 1979; 63(9-10):1659-62. PubMed ID: 91434
    [No Abstract]   [Full Text] [Related]  

  • 38. [Increase in CDDP therapeutic index by lower concentration and longer infusion time--home chemotherapy for ovarian cancer].
    Chen JT; Tatsuki Y; Hirai Y; Hasumi K
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):265-70. PubMed ID: 8434965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of advanced ovarian cancer with cis-dichlorodiammine platinum in combination with cyclophosphamide. An E.C.O.G. pilot study.
    Israel L; Aguilera J; Breau JL
    Am J Clin Oncol; 1983 Feb; 6(1):85-9. PubMed ID: 6682285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.